News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Novartis AG (NVS) Heart Drug Might Achieve Blockbuster Status


4/2/2014 8:02:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

I try to avoid using words like “blockbuster” and “breakthrough” when writing about new drugs and treatments. I’ve been disappointed too many times. But, though they’ve been in short supply lately in cardiovascular medicine, sometimes there really are breakthroughs and blockbusters. In my career writing about cardiovascular medicine I’ve seen the introduction of the ACE inhibitors, statins, stents, ICDs, and clopidogrel, among others. All of these became multibillion-dollar products and, more importantly, vastly improved the prospects for millions of people with cardiovascular disease.

Hey, check out all the research scientist jobs. Post your resume today!

Read more at Forbes.

comments powered by Disqus

Read at Forbes

comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES